AI-generated summary
The authors studied neonatal rats with hypoxic-ischemic brain damage and primary neural stem cells exposed to oxygen-glucose deprivation, treating them with photobiomodulation therapy. They report that the therapy increased neural stem cell proliferation and activated the AKT/GSK-3β/β-catenin pathway, and that inhibitors of PI3K and Wnt/β-catenin blocked this effect. The abstract does not state a total number of animals and describes findings from animal and cell experiments.
- Who or what was studied
- Neonatal rats with hypoxic-ischemic brain damage and primary neural stem cells after oxygen-glucose deprivation
- Limits stated in the abstract
- The study used animal and in vitro cell models, and the abstract does not report a total sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on atm.amegroups.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power density (irradiance)
- 5 mW/cm2, 20 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.